Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris

European Heart Journal

Volumn 17, Issue 8, 1996, Pages 1207-1215

  Hafner, G ^a   Rupprecht, H J ^a   Luz, V ^a   Terres, W ^a   Schindel, F ^a   Friesen, H J ^a   Heinrichs, H ^a   Jessels, A ^a   Meyer, J ^a   Prellwitz, W ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Markers of thrombin generation; Percutaneous transluminal coronary angioplasty; Recombinant hirudin; Therapy monitoring; Two dose regimens; Unstable angina pectoris

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; FIBRIN; HEPARIN; LEPIRUDIN; PROTHROMBIN; THROMBIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 9544240341     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a015038     Document Type: Article

References (0)